Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
schizophrenia drug
Pharma
Bristol Myers CEO stays bullish on Cobenfy despite trial flop
While Cobenfy’s new-to-brand script growth appears to be moderating lately, BMS believes it will see strong uptake “in the back end of the year.”
Angus Liu
Jun 12, 2025 12:43pm
Teva looks to peel back the onion on mental health: exec
Dec 31, 2024 8:00am
Intra-Cellular's unstoppable Caplyta nails another trial
Nov 5, 2024 10:15am
As new drugs deliver, BMS explores further efficiency moves
Oct 31, 2024 10:27am
BMS wins FDA approval for new schizophrenia med Cobenfy
Sep 26, 2024 7:38pm
BMS taps Taye Diggs for schizophrenia educational campaign
May 22, 2024 3:10pm
